ad image

Mirati Therapeutics

1 / 1
10 Promising Biotechs Aiming to Transform Medicine
Biotechs

10 Promising Biotechs Aiming to Transform Medicine

David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

PA564Mar 22, 2022
Mirati Therapeutics Presents First Clinical Data of Phase 1/2 Trial of MRTX849
Clinical Data

Mirati Therapeutics Presents First Clinical Data of Phase 1/2 Trial of MRTX849

Nice Insight

PR-M10-19-NI-043Oct 29, 2019
1 / 1